SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-120017
Filing Date
2016-05-11
Accepted
2016-05-11 13:04:47
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6631_110q.htm 10-Q 432191
2 EX-31.1 a16-6631_1ex31d1.htm EX-31.1 17837
3 EX-31.2 a16-6631_1ex31d2.htm EX-31.2 17249
4 EX-32.1 a16-6631_1ex32d1.htm EX-32.1 8627
5 EX-32.2 a16-6631_1ex32d2.htm EX-32.2 8692
  Complete submission text file 0001104659-16-120017.txt   2222493

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dprx-20160331.xml EX-101.INS 354353
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dprx-20160331.xsd EX-101.SCH 23012
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dprx-20160331_cal.xml EX-101.CAL 23712
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dprx-20160331_def.xml EX-101.DEF 67116
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT dprx-20160331_lab.xml EX-101.LAB 229004
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dprx-20160331_pre.xml EX-101.PRE 155395
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 161639137
SIC: 2834 Pharmaceutical Preparations